Retinoid-X-receptor alpha (RXRα) expression during laryngeal carcinogenesis: Detrimental or beneficial event?

Cancer Letters

Volumn 199, Issue 2, 2003, Pages 175-183

  Karamouzis, Michalis V ^a   Sotiropoulou Bonikou, Georgia ^a   Vandoros, Gerasimos ^a   Varakis, Ioannis ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Carcinogenesis; Laryngeal lesion; PPAR ; RXR

Indexed keywords

RECEPTOR SUBUNIT; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DYSPLASIA; EPITHELIUM; EPITHELIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX DISORDER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; UPREGULATION;

EID: 0142028058     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00346-X     Document Type: Article

References (40)

1. Farber E. The multistep nature of cancer development. Cancer Res. 44:1984;4217-4225.
2. Crissman J.D., Zarbo R.J. Dysplasia, in-situ carcinoma and progression to invasive carcinoma of the upper aerodigestive tract. Am. J. Surg. Pathol. 13:1989;5-12.
3. Forastiere A., Koch W., Trotti A., Sidransky D. Head and neck cancer. N. Engl. J. Med. 345:2001;1890-1900.
4. Sun S.Y., Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 41:2002;41-55.
5. Zhang W., Rashid A., Wu H., Xu X.C. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. J. Cancer Res. Clin. Oncol. 127:2001;237-242.
6. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10:1996;1031-1039.
7. Beato M., Klug J. Steroid hormone receptors: an update. Hum. Reprod. Update. 6:2000;225-236.
8. Karamouzis M.V., Gorgoulis V.G., Papavassiliou A.G. Transcription factors and neoplasia: vistas in novel drug design. Clin. Cancer Res. 8:2002;949-961.
9. Li G., Walch E., Yang X., Lippman S.M., Clifford J.L. Cloning and characterization of the human retinoid X receptor alpha gene: conservation of structure with the mouse homolog. Biochem. Biophys. Res. Commun. 269:2000;54-57.
10. Bourguet W., Andry V., Iltis C., Klaholz B., Potier N., Van Dorsselaer A., Chambon P., Gronemeyer H., Moras D. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization and preliminary X-ray results. Protein Expr. Purif. 19:2000;284-288.
11. Fang X., Hillgartner F.B. Alterations in retinoid X receptor-alpha expression contribute to cell-type dependent differences in thyroid hormone regulation of malic enzyme transcription. Mol. Cell. Endocrinol. 164:2000;41-52.
12. Prufer K., Barsony J. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol. Endocrinol. 16:2002;1738-1751.
13. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5:2000;545-555.
14. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
15. Shulman I.G., Shao G., Heyman R.A. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone-dependent activation function. Mol. Cell Biol. 18:1998;3483-3494.
16. Akiyama T.E., Baumann C.T., Sakai S., Hager G.L., Gonzalez F.J. Selective intranuclear redistribution of PPAR isoforms by RXRα Mol. Endocrinol. 16:2002;707-721.
17. Mehta R.G., Williamson E., Patel M.K., Koeffler H.P. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. J. Natl. Cancer Inst. 92:2000;418-423.
18. Boyle J.O. Retinoid mechanisms and cyclins. Curr. Oncol. Rep. 3:2001;301-305.
19. Delerive P., Wu Y., Burris T.P., Chin W.W., Suen C.S. PGC-1 functions as a transcriptional coactivator for the retinoid X receptors. J. Biol. Chem. 277:2002;3913-3917.
20. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation and development. Genes Dev. 14:2000;1553-1577.
21. Karamouzis M.V., Papadas T., Varakis I., Sotiropoulou-Bonikou G., Papavassiliou A.G. Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis. J. Cancer Res. Clin. Oncol. 128:2002;135-140.
22. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nature Cancer Rev. 1:2001;181-193.
23. Sherman J.A., Partridge M. Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia. Br. J. Oral Maxillofac. Surg. 35:1997;260-266.
24. Xu X.C., Ro J.Y., Lee J.S., Shin D.M., Hong W.K., Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 54:1994;3580-3587.
25. Egea P.F., Nitschler A., Moras D. Molecular recognition of agonist ligands by RXRs. Mol. Endocrinol. 16:2002;987-997.
26. Kliewer S.A., Sunseth S.S., Jones S.A., Bown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with PPAR alpha and gamma. Proc. Natl. Acad. Sci. USA. 94:1997;4318-4323.
27. Stoll B.A. Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention. Eur. J. Cancer Prev. 11:2002;319-325.
28. Clay C.E., Namen A.M., Atsumi G., Willingham M.C., High K.P., Kute T.E., Trimboli A.J., Fonteh A.N., Dawson P.A., Chilton F.H. Influence of J-series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis. 20:1999;1905-1911.
29. Elstner E., Muller C., Koshizuka K., Williamson E.A., Park D., Asou H., Shintaku P., Said J.W., Heber D., Koeffler H.P. Ligands for PPAR gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA. 95:1998;8806-8811.
30. Kerstan S., Desvergne B., Wahli W. Roles of PPRAs in health and disease. Nature. 405:2000;421-424.
31. Nikitakis N.G., Hebert C., Lopes M.A., Reynolds M.A., Sauk J.J. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells. Int. J. Cancer. 98:2002;817-823.
32. Dempke W., Rie C., Grothey A., Schmoll H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol. 127:2001;411-417.
33. Subbaramaiah K., Cole P.A., Dannenberg A.J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res. 62:2002;2522-2530.
34. Subbaramaiah K., Lin D.T., Hart J.C., Dannenberg A.J. Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2. J. Biol. Chem. 276:2001;12440-12449.
35. Takahashi N., Kawada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., Kawasaki H., Taira K., Yokoyama K.K., Kamei Y., Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor γ J. Biol. Chem. 227:2002;16906-16912.
36. Theocharis S., Kanelli H., Politi E., Margeli A., Karkandaris C., Philippides T., Koutselins A. Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinomas: correlation with histological type and grade. Lung Cancer. 36:2002;249-255.
37. Chan G., Boyle J.O., Yang E.K., Zhang F., Sacks P.G., Shah J.P., Edelstein D., Soslow R.A., Koki A.T., Woerner B.M., Masferrer J.L., Dannenberg A.J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59:1999;991-994.
38. Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C. Hyperphosphorylation of the retinoid X receptor α by activated c-Jun NH2-terminal kinases. J. Biol. Chem. 27:1998;18932-18941.
39. Lee S.K., Lee B., Lee J.W. Mutations in Retinoid X receptor that impair heterodimerization with specific nuclear hormone receptor. J. Biol. Chem. 43:2000;33522-33526.
40. Toyota M., Miyazaki Y., Kitamura S., Nagasawa Y., Kiyohara T., Shinomura Y., Matsuzawa Y. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1. Life Sci. 70:2002;1565-1575.